Yes, methylation is reversible. Your body removes methyl groups from DNA through both passive and active processes, and outside interventions like diet, exercise, and medications can also shift methylation patterns. This reversibility is one of the key features that distinguishes epigenetic changes from permanent genetic mutations.
About 80% of the individual DNA building blocks called CpG sites are methylated across the human genome at any given time. But this isn’t a fixed state. Methylation marks are constantly being added, maintained, and removed as part of normal cell function, development, and response to your environment.
How Your Body Removes Methyl Groups
DNA demethylation happens through two distinct routes: passive and active. Passive demethylation is the simpler of the two. Every time a cell divides and copies its DNA, the new strand starts out unmethylated. If the maintenance machinery doesn’t copy the methyl marks onto the new strand, methylation is gradually diluted with each round of cell division. This is exactly what happens to the maternal genome after fertilization, where methylation is slowly lost over several rounds of early embryonic cell division.
Active demethylation is faster and more targeted. It doesn’t require cell division at all, which means it can happen even in cells that have stopped dividing, like neurons or lens cells in the eye. Three families of enzymes drive this process. The most well-studied are the TET enzymes (TET1, TET2, and TET3), which work by chemically oxidizing the methyl group on cytosine through a series of steps. They first convert methylated cytosine into hydroxymethylcytosine, then into formylcytosine, and finally into carboxylcytosine. The cell’s DNA repair machinery then recognizes these modified bases, snips them out, and replaces them with a clean, unmethylated cytosine. TET enzymes require iron and a compound called alpha-ketoglutarate to function.
The paternal genome demonstrates just how rapid active demethylation can be. After an egg is fertilized, the father’s DNA is stripped of most of its methyl marks before the first cell division even begins.
Nutrients That Influence Methylation
Because methylation depends on a supply of methyl groups from your diet, certain nutrients directly affect how well the process works. The key players are folate, vitamin B12, choline, and betaine, all of which feed into a biochemical cycle called one-carbon metabolism that ultimately produces the methyl groups your cells use.
Folate is perhaps the most studied. In a randomized clinical trial, taking 600 micrograms of folate daily for two years significantly increased global DNA methylation in patients who had previously had colon polyps removed. Other research has shown that folate treatment can reverse DNA hypomethylation in colon tissue, though methylation returned to its previous low levels after participants switched to a placebo. The recommended daily intake of folate is 400 micrograms.
Vitamin B12 plays a critical supporting role. Animal studies have shown that B12 deprivation causes global hypomethylation even when the diet is rich in folate, highlighting that these nutrients work as a team. Adequate levels of both folate and B12 help maintain methylation at specific sites that can reduce the risk of certain precancerous changes.
Choline and betaine offer an alternative methylation pathway. Betaine directly donates a methyl group to convert homocysteine into methionine, which then becomes the universal methyl donor your cells rely on. The recommended daily intake of choline is 425 mg for women and 550 mg for men. Supplementing with 2.6 grams of choline daily for two weeks has been shown to lower homocysteine levels, a marker that rises when methylation capacity is strained.
Exercise Changes Methylation Patterns
Physical activity is one of the more accessible ways to shift your methylation landscape. A systematic review of randomized controlled trials found that exercise programs ranging from 6 weeks to 12 months produced significant changes in DNA methylation, with 12-week programs being the most commonly studied. These weren’t subtle shifts. Exercise significantly increased methylation at genes involved in bone metabolism, stress response, cell division, and inflammation.
Notably, exercise tends to push methylation in a direction that researchers associate with health: decreasing global methylation slightly while increasing methylation at specific genes linked to cancer risk and inflammatory signaling. This selective reshaping of the methylation pattern is a good example of how reversibility works in practice. Your body isn’t flipping all methylation on or off. It’s fine-tuning specific sites in response to sustained physical signals.
Medications That Reverse Methylation in Cancer
In cancer, genes that normally suppress tumor growth are often silenced by excessive methylation on their promoter regions. This is a reversible form of gene silencing, which makes it an appealing drug target. Several medications have been approved specifically to strip away these abnormal methyl marks and reactivate silenced genes.
Azacitidine (brand name Vidaza) was the first such drug approved by the FDA, in 2004, for myelodysplastic syndromes. Decitabine (Dacogen) followed in 2006 for the same condition. Both work by mimicking cytosine and getting incorporated into DNA during replication, where they trap and degrade the enzymes responsible for adding methyl groups. The result is a progressive loss of methylation across dividing cancer cells, which can reawaken tumor suppressor genes that were previously shut down.
These drugs are primarily used for blood cancers, including myelodysplastic syndromes, acute myeloid leukemia, and chronic myelomonocytic leukemia. Nearly 70 similar compounds are currently in development worldwide, reflecting the broader interest in methylation as a reversible vulnerability in cancer cells.
Lab research has also demonstrated that natural compounds can achieve something similar on a smaller scale. Genistein, a compound found in soy, was shown to reverse promoter methylation and reactivate a silenced tumor suppressor gene called BTG3 in prostate cancer cells. The same study confirmed that genistein reduced the activity of the enzymes responsible for maintaining those methyl marks.
Reversing the Epigenetic Clock
One of the most striking demonstrations of methylation reversibility comes from research on biological aging. DNA methylation patterns change predictably as you age, and researchers have built “epigenetic clocks” that estimate biological age based on methylation at specific sites across the genome. These clocks can be more accurate than chronological age at predicting health outcomes and mortality risk.
In a landmark 2019 trial known as TRIIM, researchers treated nine men with a combination of growth hormone and two diabetes-related compounds intended to regenerate the thymus gland. After one year, participants showed a mean epigenetic age approximately 2.5 years younger than expected compared to no treatment. The rate of reversal accelerated over the course of the study, going from 1.6 years of reversal per year in the first nine months to 6.5 years of reversal per year in the final three months.
Perhaps most interesting was what happened after the treatment stopped. Six months later, the participants still retained more than 1.5 years of epigenetic age reversal on average. The GrimAge clock, which specifically predicts lifespan, showed no regression at all: the approximately 2.1-year improvement measured at 12 months was still fully intact six months after the study ended. This persistence suggests that at least some methylation changes, once reversed, can be maintained by the body’s own regulatory systems.
Precision Tools for Targeted Demethylation
The newest frontier in methylation reversal uses a modified version of the gene-editing tool CRISPR. Researchers have created a system where a deactivated Cas9 protein (which can no longer cut DNA) is fused to the catalytic portion of a TET1 enzyme. This chimeric tool can be guided to a precise location in the genome, where the TET1 component strips away methyl groups without altering the underlying DNA sequence.
In colorectal cancer cell lines, this approach reduced methylation at targeted sites by 30 to 50 percent. Detailed analysis showed the demethylation effect was remarkably precise, spanning only 50 to 150 base pairs from the guide RNA’s target site. Researchers used this system to screen 88 abnormally hypermethylated regions in colorectal cancer, identifying which ones functionally contribute to cancer progression when their methylation is reversed. More advanced platforms are now combining demethylation with other epigenetic modifications at the same site, improving the ability to fully reactivate silenced genes.
What Makes Some Methylation Changes Stick
While methylation is technically reversible at every site in your genome, not all methylation changes reverse equally easily in practice. Maintenance enzymes actively copy methylation patterns onto new DNA strands during cell division, which means well-established methylation marks tend to persist unless something actively disrupts them. This is why cancer cells can maintain abnormal methylation patterns through hundreds of cell divisions, and why imprinted genes (where one parent’s copy is permanently silenced) remain methylated throughout your entire life.
The context also matters. Methylation at CpG-rich regions near gene promoters, called CpG islands, is typically kept low in healthy cells and is relatively easy to restore if it becomes abnormally elevated. Methylation across the vast stretches of repetitive DNA between genes is normally high and tends to decrease with age, a pattern that appears harder to fully reverse. The durability of any methylation reversal depends on whether the signals that caused the original change are still present, whether the cell is actively dividing, and whether the local chromatin environment supports the new methylation state.